Skip to content

A Clinical study on Alli Choornam in management of Kapha Neerizhivu noi(Diabetic Peripheral Neuropathy)

A Prospective Open Labelled non randomized phase II Clinical trial on Alli Choornam in management of Kapha Neerizhivu noi(Diabetic Peripheral Neuropathy)

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/02/023625
Enrollment
60
Registered
2020-02-27
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E114- Type 2 diabetes mellitus with neurological complications

Interventions

Intervention1: Alli Chooranam: 72 mg/Kg/BW/twice a day A/F 90 days Control Intervention1: Nil: Nil

Sponsors

Government Siddha Medical College and Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Previously diagnosed Type II Diabetes patients having Fasting blood sugar more than 110 mg/dl Postprandial more than 140 mg/dl Random blood sugar 180 mg/dl HbA1C more than 7 with peripheral neuropathy(Sensory)

Exclusion criteria

Exclusion criteria: Type I Diabetes mellitus Diabetes Insipidus Gestational Diabetes mellitus Chronic Kidney diseases having S Creatinine more than 2 mg/dl Motor neuron disease Presence of foot ulcer Myopathy

Design outcomes

Primary

MeasureTime frame
During treatment or after treatment reduction of following symptoms Glucose level within normal limit HbA1C below 6mg/dl Reduction in numbness in the limbs reduction in general tiredness,malaise.Timepoint: 90 days

Secondary

MeasureTime frame
Evaluation of physicochemical,phytochemical,pharmacological activities of Alli Chooranam. Evaluation of Siddha parameters (including Envagai thervu) in Kapha Neerizhivu during trial period. Evaluation of safety profile for acute and Sub acute toxicity of trial drug.Timepoint: 90 days

Countries

India

Contacts

Public ContactDr A Manoharan MD S PhD

Government Siddha Medical College & Hospital Palayamkottai

drmanoharan25@gmail.com9443886700

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026